SECsense Logo

Salarius Pharmaceuticals 8-K Report: Key Updates & Insights - January 2025

$SLRX
Form 8-K
Filed on: 2025-01-13
Source
Salarius Pharmaceuticals 8-K Report: Key Updates & Insights - January 2025

Based on the provided section of the financial report, here are the key pieces of information extracted:

  1. Entity Information:
  • Company Name: Salarius Pharmaceuticals, Inc.
  • CIK Number: 0001615219
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-36812
  • EIN: 46-5087339
  • Address: 2450 Holcombe Blvd., Suite X, Houston, TX 77021
  • Phone Number: 713-560-8xxx (phone number appears incomplete)
  1. Filing Information:
  • Filing Type: 8-K (current report)
  • Filing Date: January 10, 2025
  1. Securities Information:
  • Type of Security: Common Stock
  • Par Value: $0.0001
  • Ticker Symbol: SLRX
  1. Period of Reporting:
  • Report Date: January 10, 2025

Insights:

  • The filing is a Form 8-K, which typically indicates that the company is reporting significant events or changes that shareholders should be aware of.
  • The information is current as of the date of filing, which suggests that any significant corporate events or updates would be disclosed around this date.
  • The company is listed under the common stock category with a very low par value, which could imply a focus on growth and investment rather than dividends at this stage.

This summary captures the essential details from the provided section of the financial report, reflecting both the company specifics and the nature of the filing.